Test ID EPOR Erythropoietin Receptor (EPOR) Gene, Exon 8 Sequencing
Useful For
Only orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Testing Algorithm
This test does not provide a serum erythropoietin (Epo) level. If Epo testing is desired, see EPO / Erythropoietin (EPO), Serum.
This evaluation is recommended for patients presenting with lifelong erythrocytosis, usually with a positive family history of similar symptoms. Polycythemia vera should be excluded prior to testing as it is much more common than hereditary erythrocytosis and can be present even in young patients. A JAK2 V617F or JAK2 exon 12 mutation should not be present. Additionally, p50 testing should be performed and a normal result confirmed before ordering this test. For a complete evaluation including p50 testing, hemoglobin electrophoresis testing, and hereditary erythrocytosis mutation analysis in an algorithmic fashion, order the erythrocytosis evaluation panel (REVP / Erythrocytosis Evaluation).
Method Name
Only orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Polymerase Chain Reaction (PCR) Amplification/Sanger Sequence Analysis
Reporting Name
EPOR Gene, Mutation Analysis, BSpecimen Type
Whole bloodOnly orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Whole blood | Refrigerated | 30 days |
Clinical Information
Only orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Reference Values
Only orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Cautions
Only orderable as part of a profile. For more information see HEMP / Hereditary Erythrocytosis Mutations.
Performing Laboratory

Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.CPT Code Information
81479-Unlisted molecular pathology procedure